glp 1 side effects gastroparesis New data links GLP-1 agonists for weight loss with higher risk for pancreatitis, GI events Ozempic Lawsuit for Gastroparesis |

The main difference lies in their uses: Wegovy is typically titrated up to 2.4 mg for weight management, while Ozempic is used at lower doses for diabetes

Ghrelin Ghrelin is a 28-amino acid peptide and is the only orexigenic hormone recognized in humans

The FDA approved the first semaglutide drug for weight loss more than a decade ago, but the so-called GLP-1 market exploded more recently, after the 2021 greenlighting of the GLP-1 drug Wegovy for weight management

for example, their analysis identified a significant increase in the risk of drug-induced pancreatitis, whereas our review did not find a statistically significant association

Store in the original box or wrap the vial in aluminum foil

Semaglutide is marketed as Wegovy for weight management and Ozempic for type 2 diabetes, though Ozempic is commonly prescribed off-label for weight management